Literature DB >> 2720866

Effects of halothane on arrhythmias induced by myocardial ischaemia.

B A MacLeod1, R McGroarty, R H Morton, M J Walker.   

Abstract

The effect of halothane on arrhythmias induced by ischaemia was investigated in rats, isolated perfused rat hearts, and pigs. Responses to the occlusion of the left anterior descending coronary artery were determined in groups (n = 9) of chronically prepared rats treated with no halothane, 0.5, or 1.0 per cent halothane immediately after occlusion; in isolated rat hearts (n = 10) treated with no halothane, 0.5, 1.0, 2.0, or 4.0 per cent halothane for 15 min before and after occlusion; and 20-25 kg pigs (n = 11) anaesthetised with halothane or pentobarbital. The ECG, arrhythmias, blood pressure (BP), heart rate (HR) and extent of infarction were determined in each model. In pigs, left ventricular pressure, dp/dtmax and cardiac output were also measured. In chronically prepared rats, halothane anaesthesia started after occlusion was antiarrhythmic and decreased the incidence of ventricular fibrillation and resulting mortality. In isolated rat hearts, 0.5 or 1.0 per cent halothane had little effect on occlusion-induced arrhythmias. The highest concentration of halothane increased the incidence of ventricular fibrillation both before and after occlusion. Halothane decreased developed ventricular pressure in a dose-dependent manner. In acutely prepared pigs, halothane pre-treatment had no appreciable effect upon occlusion-induced arrhythmias when compared with pentobarbital anaesthesia. Thus, halothane is antiarrhythmic when treatment is initiated after occlusion in the rat but this action is not seen in isolated hearts or intact pigs. The antiarrhythmic action of halothane is, therefore, species and model dependent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720866     DOI: 10.1007/BF03010767

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  16 in total

1.  Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity.

Authors:  M M NACHLAS; T K SHNITKA
Journal:  Am J Pathol       Date:  1963-04       Impact factor: 4.307

2.  Effect of chronic cardiac denervation on arrhythmias after coronary artery ligation.

Authors:  P A Ebert; R B Vanderbeek; R J Allgood; D C Sabiston
Journal:  Cardiovasc Res       Date:  1970-04       Impact factor: 10.787

3.  Myocardial functional and metabolic responses to ischemia in swine during halothane and fentanyl anesthesia.

Authors:  R G Merin; P D Verdouw; J W de Jong
Journal:  Anesthesiology       Date:  1982-02       Impact factor: 7.892

4.  Anesthetic uptake--of mice and men (and whales).

Authors:  E A Wahrenbrock; E I Eger; R B Laravuso; G Maruschak
Journal:  Anesthesiology       Date:  1974-01       Impact factor: 7.892

5.  Halothane depression of myocardial slow action potentials.

Authors:  C Lynch; S Vogel; N Sperelakis
Journal:  Anesthesiology       Date:  1981-10       Impact factor: 7.892

6.  Calcium transport by cardiac sarcoplasmic reticulum: modulation of halothane action by substrate concentration and pH.

Authors:  T J Blanck; M Thompson
Journal:  Anesth Analg       Date:  1981-06       Impact factor: 5.108

7.  Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat.

Authors:  M J Curtis; B A MacLeod; M J Walker
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

8.  Antifibrillatory effects of volatile anesthetics in acute occlusion/reperfusion arrhythmias.

Authors:  D A Kroll; P R Knight
Journal:  Anesthesiology       Date:  1984-12       Impact factor: 7.892

9.  A model of ventricular fibrillation in the isolated rat heart.

Authors:  B Woodward
Journal:  J Pharmacol Methods       Date:  1981-11

10.  An improved perfusion apparatus for small animal hearts.

Authors:  M J Curtis; B A Macleod; R Tabrizchi; M J Walker
Journal:  J Pharmacol Methods       Date:  1986-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.